IL6 and carcinoma of supraglottis: In patients with early-stage (T1-T2, N0, M0) laryngeal cancer, those with glottic cancer have significantly lower IL-6 serum levels compared with those with supraglottic cancer, while there was no difference between laryngeal subsites in advanced stages [44].